These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 22387599

  • 21. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, Qu A, Zhang X, Pan H, Yang Y, Wang C.
    Int J Cancer; 2015 Feb 15; 136(4):854-62. PubMed ID: 24961907
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
    Aydoğdu E, Katchy A, Tsouko E, Lin CY, Haldosén LA, Helguero L, Williams C.
    Carcinogenesis; 2012 Aug 15; 33(8):1502-11. PubMed ID: 22562546
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
    Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W, Bai C.
    Oncol Rep; 2010 Jan 15; 23(1):121-8. PubMed ID: 19956872
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
    Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H.
    J Clin Oncol; 2010 Apr 01; 28(10):1721-6. PubMed ID: 20194856
    [Abstract] [Full Text] [Related]

  • 29. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 30. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB, Appaiah HN, Burnett RM, Bhat-Nakshatri P, Wang G, Mehta R, Badve S, Thomson MJ, Hammond S, Steeg P, Liu Y, Nakshatri H.
    Oncogene; 2011 Mar 17; 30(11):1290-301. PubMed ID: 21057539
    [Abstract] [Full Text] [Related]

  • 31. Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women.
    Yang Q, Lu J, Wang S, Li H, Ge Q, Lu Z.
    Clin Chim Acta; 2011 Nov 20; 412(23-24):2167-73. PubMed ID: 21840305
    [Abstract] [Full Text] [Related]

  • 32. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C.
    Int J Cancer; 2013 Jan 01; 132(1):116-27. PubMed ID: 22674182
    [Abstract] [Full Text] [Related]

  • 33. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
    Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA.
    Mol Cancer Res; 2012 Apr 01; 10(4):504-15. PubMed ID: 22343615
    [Abstract] [Full Text] [Related]

  • 34. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.
    Cancer Res; 2010 May 15; 70(10):4163-73. PubMed ID: 20442294
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S, Keerthana R, Pazhanimuthu A, Perumal P.
    Indian J Biochem Biophys; 2013 Jun 15; 50(3):210-4. PubMed ID: 23898484
    [Abstract] [Full Text] [Related]

  • 38. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
    Mishra S, Srivastava AK, Suman S, Kumar V, Shukla Y.
    Cancer Lett; 2015 Dec 01; 369(1):67-75. PubMed ID: 26276721
    [Abstract] [Full Text] [Related]

  • 39. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M.
    Int J Oncol; 2011 Aug 01; 39(2):409-15. PubMed ID: 21567082
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.